Bayer’s oncology business looks to collect $10B in sales by 2030
Some experts say FDA made the right call on Lilly's donanemab
Promising IPF treatment results sent Pliant Therapeutics stock soaring
Law firms target Spectrum over lung cancer trial statements
*please scroll down for all the latest news*
